CIK 0000894158 · Non-accelerated filer<br>Smaller reporting company
Theriva Biologics, Inc.
Sign in to watch- Ticker
- TOVX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 133808303
- Phone
- (734) 332-7800
- Business address
- 9605 MEDICAL CENTER DRIVE, SUITE 270, ROCKVILLE, MD, 20850
- Former names
- Synthetic Biologics, Inc., ADEONA PHARMACEUTICALS, INC., PIPEX PHARMACEUTICALS, INC., SHEFFIELD PHARMACEUTICALS INC, SHEFFIELD MEDICAL TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 35 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-04-17 | Ballantyne Charles Evan Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +150,000 | 150,000 | ||
| 2014-04-17 | Riley Jeffrey Scott CEO and President | Grant or award · Stock Options (Right to Buy) | +500,000 | 500,000 | ||
| 2014-04-17 | Wolf Jeffrey Alan Director | Grant or award · Stock Options (Right to Buy) | +105,000 | 105,000 | ||
| 2014-04-17 | Kraws Jeffrey J Director | Grant or award · Stock Options (Right to Buy) | +105,000 | 105,000 | ||
| 2013-12-17 | KIRK RANDAL J 10% owner | Purchase | +500,000 | $1.00 | $500K | 3,625,000 |
| 2013-12-17 | KIRK RANDAL J 10% owner | Purchase | +2,000,000 | $1.00 | $2.0M | 8,675,768 |
| 2013-10-22 | Kraws Jeffrey J Director | Grant or award · Stock Options | +25,000 | 412,105 | ||
| 2013-10-22 | Tarriff Scott Director | Grant or award · Stock Options | +25,000 | 75,000 | ||
| 2013-10-22 | Wolf Jeffrey Alan Director | Grant or award · Stock Options | +25,000 | 133,332 | ||
| 2013-03-05 | Wolf Jeffrey Alan Director | Grant or award · Stock Options | +25,000 | $1.74 | $44K | 108,332 |
| 2013-03-05 | Tarriff Scott Director | Grant or award · Stock Options | +25,000 | $1.74 | $44K | 50,000 |
| 2013-01-07 | Riley Jeffrey Scott CEO and President | Purchase | +5 | $1.71 | $9 | 7,505 |
| 2013-01-07 | Riley Jeffrey Scott CEO and President | Purchase | +2,895 | $0.17 | $498 | 10,400 |
| 2013-01-03 | Riley Jeffrey Scott CEO and President | Purchase | +2,000 | $1.71 | $3K | 7,500 |
| 2013-01-03 | Riley Jeffrey Scott CEO and President | Purchase | +2,800 | $1.75 | $5K | 5,500 |
| 2013-01-02 | Riley Jeffrey Scott CEO and President | Purchase | +2,700 | $1.78 | $5K | 2,700 |
| 2012-10-29 | KIRK RANDAL J 10% owner | Purchase | +3,125,000 | $1.60 | $5.0M | 3,125,000 |
| 2012-05-10 | Kraws Jeffrey J Director | Grant or award · Stock Options | +100,000 | 387,105 | ||
| 2012-02-03 | Riley Jeffrey Scott CEO and President | Grant or award · Stock Options | +750,000 | 908,333 | ||
| 2011-11-17 | Riley Jeffrey Scott Director | Grant or award · Stock Options | +100,000 | 158,333 |
Page 5 of 6 · 113 trades